Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen C Mack

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Cell|November 6, 2018
N<sup>6</sup>-methyladenine DNA Modification in GlioblastomaQi Xie, Tao P Wu, Ryan C Gimple, et al.
Cancer Cell|December 3, 2015
MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing ChromatinMarco Gallo, Fiona J Coutinho, Robert J Vanner, et al.
Cancer Discovery|September 24, 2020
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of BoneSima Khazaei, Nicolas De Jay, Shriya Deshmukh, et al.
Cell Death and Differentiation|April 9, 2024
IFI35 regulates non-canonical NF-κB signaling to maintain glioblastoma stem cells and recruit tumor-associated macrophagesDaqi Li, Xiefeng Wang, Kexin Chen, et al.
Nature Genetics|December 5, 2022
K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomasSelin Jessa, Abdulshakour Mohammadnia, Ashot S Harutyunyan, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesisYi Xiao, Diana D Shi, Lei Guo, et al.
Neuro-Oncology|May 4, 2026
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymomaSiri M Ippagunta, Amir Arabzade, Srinidhi Varadharajan, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated MacrophagesWei Yuan, Qian Zhang, Danling Gu, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Cancer Cell|May 16, 2019
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M GliomasBrian Krug, Nicolas De Jay, Ashot S Harutyunyan, et al.
Cell|November 6, 2018
N<sup>6</sup>-methyladenine DNA Modification in GlioblastomaQi Xie, Tao P Wu, Ryan C Gimple, et al.
Cancer Cell|December 3, 2015
MLL5 Orchestrates a Cancer Self-Renewal State by Repressing the Histone Variant H3.3 and Globally Reorganizing ChromatinMarco Gallo, Fiona J Coutinho, Robert J Vanner, et al.
Cancer Discovery|September 24, 2020
H3.3 G34W Promotes Growth and Impedes Differentiation of Osteoblast-Like Mesenchymal Progenitors in Giant Cell Tumor of BoneSima Khazaei, Nicolas De Jay, Shriya Deshmukh, et al.
Cell Death and Differentiation|April 9, 2024
IFI35 regulates non-canonical NF-κB signaling to maintain glioblastoma stem cells and recruit tumor-associated macrophagesDaqi Li, Xiefeng Wang, Kexin Chen, et al.
Nature Genetics|December 5, 2022
K27M in canonical and noncanonical H3 variants occurs in distinct oligodendroglial cell lineages in brain midline gliomasSelin Jessa, Abdulshakour Mohammadnia, Ashot S Harutyunyan, et al.
Biorxiv : the Preprint Server for Biology|August 20, 2025
Mutant IDH silences GSX2 to reprogram neural progenitor cell fate and promote gliomagenesisYi Xiao, Diana D Shi, Lei Guo, et al.
Neuro-Oncology|May 4, 2026
Nuclear export as a therapeutic vulnerability in ZFTA-RELA ependymomaSiri M Ippagunta, Amir Arabzade, Srinidhi Varadharajan, et al.
Cell|October 22, 2013
Hypermutation of the inactive X chromosome is a frequent event in cancerNatalie Jäger, Matthias Schlesner, David T W Jones, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2023
Dual Role of CXCL8 in Maintaining the Mesenchymal State of Glioblastoma Stem Cells and M2-Like Tumor-Associated MacrophagesWei Yuan, Qian Zhang, Danling Gu, et al.
Pageof 10